2026-09-01 19:58:54
Click:
The integration of China's pharmaceutical equipment industry and AI has evolved from 'functional addition' to 'native core', driving the industry from homogeneous competition to a new stage of high-quality development centered on intelligence and ecology. The depth of its integration is reflected in three aspects: first, device intelligence, with AI deeply embedded in high-end imaging equipment (such as Neusoft Medical's world's first wide body photon counting CT and GE Medical Quantum Platform CT), achieving 'photon direct reading', ultra high definition imaging, and radiation dose reduction of over 90%. Ocean data processing makes AI empowerment an inevitable choice. The second is the reconstruction of the diagnosis and treatment process, with the medical vertical domain model (such as Mindray Medical's seven Qiyuan specialty models covering critical illness, perioperative period, and testing) as the core, constructing an intelligent closed-loop system from auxiliary diagnosis, disease monitoring to automatic medical record generation (completed in 1 minute), compressing the imaging diagnosis time from 20 minutes to 3 minutes, significantly improving treatment efficiency and medical homogenization level. The third is innovation in ecology and services. Industry leaders are promoting the transformation of medical devices from functional tools to active health management partners with emotions and thinking through the 'device+IT+AI' overall solution (such as JD Health JoyInside access protocol plan to achieve 20 billion sales in three years), and building the world's largest intelligent interconnected ecological network. This deep integration not only solves long-term pain points such as insufficient grassroots medical capabilities and data silos, but also enables China to rank first in the world in the research and development of AI medical devices, injecting core driving force for the leapfrog development of the industry.